Last reviewed · How we verify
Acute hypotensive states in adult patients
Approved treatments
- Levophed · Pfizer Inc.
Peripheral vasoconstrictor via alpha-adrenergic action and cardiac inotropic stimulator with coronary vasodilation via beta-adrenergic action.
Clinical guidelines
- FDA label — 1L
Norepinephrine bitartrate injection is indicated for restoration of blood pressure in adult patients with acute hypotensive states. - FDA label — 1L
Norepinephrine bitartrate injection is indicated for restoration of blood pressure in adult patients with acute hypotensive states.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute hypotensive states in adult patients patent landscape — cliff calendar, originator estates, attackable patents
- Acute hypotensive states in adult patients treatment landscape brief
- Acute hypotensive states in adult patients treatment updates RSS
Frequently asked questions about Acute hypotensive states in adult patients
What drugs treat Acute hypotensive states in adult patients?
Tracked treatments include Levophed.
What is the treatment for Acute hypotensive states in adult patients?
Standard treatment for Acute hypotensive states in adult patients includes Levophed. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Acute hypotensive states in adult patients?
FDA label publishes guidelines for Acute hypotensive states in adult patients. 2 guideline references tracked.
Related
- Treatment landscape: Acute hypotensive states in adult patients patent cliff · Acute hypotensive states in adult patients CI report
- Treatment: Levophed · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing